Clinical Trial: Correlation between circulating tumor DNA site mutations and primary central nervous system lymphoma being diffuse large B-cell lymphoma: a basic research based on CRISPR high-sensitivity biosensor enrichment detection of circulating tumor DNA for noninvasive diagnosis of central nervous system lymphoma (China)

China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation between circulating tumor DNA site mutations and primary central nervous system lymphoma being diffuse large B-cell lymphoma: a basic research based on CRISPR high-sensitivity biosensor enrichment detection of circulating tumor DNA for noninvasive diagnosis of central nervous system lymphoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129950

Registration Time: 2026/08/12

Type: Diagnostic test

Primary Sponsor: Peking University Shenzhen Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337111

Published by HT Digital Content Servi...